Lithium-Enhanced Bone Scaffold Promotes Immune-Guided Bone Regeneration

Repairing damaged bone is not simply a matter of filling a structural gap. Successful bone healing depends on a carefully orchestrated interaction between immune cells, blood vessels, and bone-forming cells. When bone is injured, immune cells such as macrophages arrive first. Initially, they trigger inflammation to remove debris and protect against infection. Over time, they must transition into a repair-supporting state, known as the M2 phenotype, which encourages tissue regeneration. If this immune balance is disrupted, healing may be delayed or incomplete. Designing biomaterials that actively guide immune responses has therefore become an important frontier in regenerative medicine.

In this study, researchers developed a bone scaffold made from calcium silicate doped with lithium ions. Traditional scaffolds provide structural support, but they often act as passive frameworks. The innovation here was to create a scaffold that could directly influence immune cell behavior. Lithium is known to modulate signaling pathways involved in tissue regeneration, and the researchers hypothesized that incorporating lithium into the scaffold could help steer macrophages toward a healing-promoting phenotype.

Laboratory experiments showed that macrophages cultured on lithium-doped scaffolds were more likely to adopt the M2 phenotype. These M2 macrophages released extracellular vesicles enriched in the specific regulatory microRNA-145-5p (miR-145-5p). MicroRNAs are small RNA molecules that influence gene expression. In this case, miR-145-5p played a key role in stimulating osteogenic differentiation, the process by which stem cells develop into bone-forming cells, and in promoting angiogenesis, the formation of new blood vessels.

When tested in bone defect models, the lithium-doped scaffolds significantly enhanced bone regeneration compared to non-doped scaffolds. The treated sites showed more robust bone matrix deposition and improved vascularization. Importantly, the regenerative effects appeared to result not from direct stimulation of bone cells alone, but from reshaping the immune environment first. By encouraging macrophages to transition into a pro-healing state, the scaffold created conditions that naturally supported coordinated tissue repair.

The uniqueness of this research lies in its concept of osteoimmunomodulation, the idea that bone regeneration and immune regulation are inseparable processes. Instead of viewing inflammation as something to suppress entirely, the study recognizes that properly guided immune responses are essential for effective healing. The scaffold acts as more than a structural implant; it functions as a biological conductor, aligning immune signals with regenerative needs.

If translated into clinical practice, such immune-responsive scaffolds could improve outcomes in complex bone injuries, fractures, and orthopedic surgeries. By accelerating healing and reducing complications, they may shorten recovery time and enhance patients’ quality of life. As the population ages and demand for orthopedic interventions increases, materials that work in harmony with the body’s immune system may play an increasingly important role in advancing regenerative medicine.